EHC / Encompass Health's (EHC) Q3 Earnings Beat on Discharge Growth

Encompass Health (EHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement more_horizontal

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects a more_horizontal

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2023, it c more_horizontal

Encompass Health's (EHC) Q3 results are likely to reflect improved inpatient volumes and bed additions, offset by higher operating expenses. more_horizontal

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves. more_horizontal

Here is how Encompass Health (EHC) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year. more_horizontal

The Rehabilitation Hospital of Columbus is Encompass Health's (EHC) sixth location in the state of Georgia. more_horizontal